SPC for ezetimibe/simvastatin considered invalid in preliminary relief proceedings
Targeted treatments – Part 3: the power of orphan drug protection
German Federal Court of Justice invalidates Truvada SPC
Targeted treatments – Part 1: Targeted treatments: patents for particular populations
CJEU ruling to liberalise parallel import in Poland
Biologics and biosimilars litigation update
Return to work: key issues for life sciences
by Helen Farr and Adrian Toutoungi
Private equity investment in life sciences sector
Exploring some of the potential benefits and challenges for life sciences companies considering PE investment.
by multiple authors
4 of 6 Insights
Licensing out: Try not to get benched
by Colin McCall and Justyna Ostrowska